PhiloGene will debut its revolutionary advances in understanding the biology and the treatment of cancer and macular degeneration to a group of eminent venture capitalists and executives from pharmaceutical and biotechnology companies.
PhiloGene, through collaboration with Professor David Bates and Dr. Steve Harper at Bristol University in the UK, have found that a novel form [...]

Continue reading " Revolutionary Advances in the Treatment of Cancer and Macular Degeneration "